Biogen Inc Stock In The News

BIIB Stock  USD 194.11  0.27  0.14%   
The overall news coverage of Biogen Inc from major news outlets shows bullish sentiment on 24 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of Biogen's news coverage and content from conventional and social sources shows investors' bearish mood towards Biogen Inc. The specific impact of Biogen news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Biogen's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Biogen headlines in addition to utilizing other, more conventional financial analysis modules. Check out Biogen Backtesting and Biogen Hype Analysis.

Biogen Today Top News and Investor Outlook

Yahoo News
What's in Store for Biogen (BIIB) This Earnings Season?
https://finance.yahoo.com/news/whats-store-biogen-biib-earnings-133900554.html
 Bullish
Yahoo News
Gear Up for Biogen (BIIB) Q1 Earnings: Wall Street Estimates for Key Metrics
https://finance.yahoo.com/news/gear-biogen-biib-q1-earnings-131524284.html
 Bullish
Yahoo News
Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
https://finance.yahoo.com/news/analysts-estimate-gilead-sciences-gild-140139125.html
 Bullish
Yahoo News
Biogen Inc. (BIIB) Reports Next Week: Wall Street Expects Earnings Growth
https://finance.yahoo.com/news/biogen-inc-biib-reports-next-140122361.html
 Bullish
Yahoo News
3 Stocks Wall Street Is Ignoring (But You Shouldn’t): April Edition
https://finance.yahoo.com/news/3-stocks-wall-street-ignoring-110000216.html
 Bullish
Yahoo News
12 Best S&P 500 Stocks To Buy According to Analysts
https://finance.yahoo.com/news/12-best-p-500-stocks-155315533.html
 Bullish
Yahoo News
CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug
https://finance.yahoo.com/news/chmp-delay-nod-biogen-biib-152100351.html
 Bullish
Yahoo News
Biogen Inc. (BIIB) Dips More Than Broader Market: What You Should Know
https://finance.yahoo.com/news/biogen-inc-biib-dips-more-215019278.html
 Bullish
Yahoo News
Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
https://finance.yahoo.com/news/wall-street-favorite-biotech-stocks-190000969.html
 Bullish
Yahoo News
Labcorp (LH) Boost Diagnostics Suite With New Biomarker Test
https://finance.yahoo.com/news/labcorp-lh-boost-diagnostics-suite-110300172.html
 Bullish

Biogen Inc Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Biogen and other traded companies coverage. We help investors stay connected with Biogen headlines for the 23rd of April to make an informed investment decision based on correlating the impacts of news items on Biogen Stock performance. Please note that trading solely based on the Biogen Inc hype is not for everyone as timely availability and quick action are needed to avoid losses.
Biogen's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Biogen Inc investors visualize upcoming and past events in order to time the market based on Biogen Inc noise-free hype analysis.
Biogen stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Biogen earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Biogen that are available to investors today. That information is available publicly through Biogen media outlets and privately through word of mouth or via Biogen internal channels. However, regardless of the origin, that massive amount of Biogen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biogen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biogen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biogen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biogen alpha.

Biogen Largest EPS Surprises

Earnings surprises can significantly impact Biogen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2000-07-18
2000-06-300.080.090.0112 
1999-04-20
1999-03-310.030.040.0133 
1999-02-09
1998-12-310.040.050.0125 
1998-02-05
1997-12-310.050.060.0120 
1996-10-30
1996-09-30-0.05-0.040.0120 
2000-02-02
1999-12-310.070.05-0.0228 
View All Earnings Estimates

Biogen Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Biogen Inc Stock. Current markets are strongly bullish. About 76% of major world exchanges and indexes are currently up. See today's market update for more information.
Usa forbes News
19th of April 2024
Pfizer On The New Lows List. Big Dividend Fails To Attract Buyers.
at forbes.com 
Yahoo News
18th of April 2024
Alzheimers Therapeutics Market Size Expected to Surpass USD 8.18 Bn by 2032
at finance.yahoo.com 
Yahoo News
17th of April 2024
Biogen Inc. Reports Next Week Wall Street Expects Earnings Growth
at finance.yahoo.com 
Yahoo News
16th of April 2024
QuantHealth Appoints Esteemed Pharmaceutical Executives to Inaugural Advisory Board
at finance.yahoo.com 
news
15th of April 2024
STAT Can investing in infectious disease pay off Vir Biotechnologys tightrope walk shows i...
at statnews.com 
Yahoo News
12th of April 2024
EISAI TO PRESENT DATA ON ROBUST NEUROLOGY PORTFOLIO AT THE 76th AMERICAN ACADEMY OF NEUROL...
at finance.yahoo.com 
Street Insider News
11th of April 2024
INVESTOR CALLVirtualwares CEO to present Annual Report to shareholders
at streetinsider.com 
Investing News at Macroaxis
4th of April 2024
Biogens head of development sells shares worth over 19k
at investing.com 
Yahoo News
28th of March 2024
Morningstar unveils 10 cheap stocks with big moats
at finance.yahoo.com 
Yahoo News
21st of March 2024
Hedge Funds and Insiders Are Buying These 10 Stocks
at finance.yahoo.com 

Biogen Investors Sentiment

The influence of Biogen's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Biogen. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Biogen's public news can be used to forecast risks associated with an investment in Biogen. The trend in average sentiment can be used to explain how an investor holding Biogen can time the market purely based on public headlines and social activities around Biogen Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Biogen's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Biogen's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Biogen's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Biogen.

Biogen Implied Volatility

    
  66.66  
Biogen's implied volatility exposes the market's sentiment of Biogen Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Biogen's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Biogen stock will not fluctuate a lot when Biogen's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biogen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biogen's short interest history, or implied volatility extrapolated from Biogen options trading.
When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:

Complementary Tools for Biogen Stock analysis

When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.55)
Earnings Share
7.97
Revenue Per Share
67.972
Quarterly Revenue Growth
(0.06)
Return On Assets
0.0458
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.